Anxiety Insights
sponsored by

Endsleigh offer competitive
Life Insurance policies


««
January 2007
»»
S M
T
W T F S
  1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29 30 31
Archives
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
Search
 
LinkBlog
  • NIMH sponsored postpartum depression site
  • Acupressure points for relieving anxiety and nervousness
  • The limits of rational thought
  • Full LinkBlog
Blog Board
Name 

(Note: anti spam delay set)
Contact

Mailing List
RSS Feed

 
Translations

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.
anti torture campaign
Hit Counter
Total: 341,421
Last Reset: 04:05, 14 May 06
Login Console

Log-In

My Blog    My Profile

Leave Message

Add as neighbor





Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Bloggapedia - Find It!

Escitalopram (Cipralex®,Lexapro®) gains EU approval for OCD

Escitalopram (Cipralex®, Lexapro®) has been approved in the EU for the treatment of obsessive compulsive disorder (OCD) by the Swedish Medical Products Agency (MPA) acting as reference member state for the European Union (EU). The approval is based on clinical studies involving more than 750 patients, which demonstrate that escitalopram is an effective and well-tolerated drug in the treatment of OCD with the added benefit of significantly reducing the risk of relapse in OCD patients.

"With the approval for the treatment of OCD, Cipralex® is now approved for the treatment of all major anxiety indications and depression," said Senior Vice President Anders Gersel Pedersen, Head of Development at Danish pharmaceutical company Lundbeck H. Lundbeck A/S.

Comments invited
Trackback
Trackback URL: https://anxietyinsights.info/read/trackback/411917041.htm
Hosted by Blog-City v5.0a
Terms & Conditions of this blogcity site